FUSMobile is an innovative brand that specializes in non-invasive solutions for chronic painful conditions. They strive to improve the patient experience and clinical outcomes while reducing costs. One of their cutting-edge products is the Neurolyser, a focused ultrasound treatment platform designed to non-invasively destroy nerve cells and provide relief for chronic low back pain, such as facet arthritis, and other common painful conditions.

Founded in 2014 by Arik Hananel, MD, and Ron Aginsky, LLB, MBA, FUSMobile was created in response to a need for a compact, mobile, and user-friendly focused ultrasound device. In just under five years, the company successfully completed a pilot clinical trial using their Neurolyser device, showcasing their dedication to advancing pain treatment. The Neurolyser device utilizes image-guided high-intensity focused ultrasound ablation, allowing for noninvasive alleviation of chronic pain at a reduced cost.

FUSMobile's groundbreaking approach has garnered attention and recognition within the medical community. Their commitment to innovation and improving the lives of those suffering from chronic pain sets them apart in the field